[{"id":"681c986d-7eea-4d59-95e0-5ddb2b17df49","acronym":"LB1901-TCL-1001","url":"https://clinicaltrials.gov/study/NCT04712864","created_at":"2021-01-19T20:52:46.996Z","updated_at":"2024-07-02T16:35:34.942Z","phase":"Phase 1","brief_title":"Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma","source_id_and_acronym":"NCT04712864 - LB1901-TCL-1001","lead_sponsor":"Legend Biotech USA Inc","biomarkers":" TNFRSF8 • CD4","pipe":"","alterations":" ","tags":["TNFRSF8 • CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e LB1901"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 50","initiation":"Initiation: 09/13/2021","start_date":" 09/13/2021","primary_txt":" Primary completion: 12/01/2023","primary_completion_date":" 12/01/2023","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2023-10-03"}]